Latest News

On Friday 21 October 2011, the European Myeloma Platform (EMP) and Myeloma Euronet (ME) merged to become Myeloma Patients Europe.
Both organisations strongly believe that joining forces will provide a robust network and offer huge benefits to myeloma patients and their families across Europe. Their work will be more effective, efficient and sustainable and their capacity to play a role among other stakeholders in the European myeloma, cancer and health scenes will increase considerably. Consequently they have taken the decision to merge and to create an entirely new European umbrella organisation of Myeloma Patients Groups.
Their website is under construction www.myelomapatientseurope.org.
For the foreseeable future, the existing websites of EMP and ME will remain operational.

To contact MPE, please email info@myelomapatientseurope.org or contact Philip Bloom philip.bloom@myeloma-euronet.org or Lia Van Ginneken l.vanginneken@emp-myeloma.eu

Download the entire press release

European Myeloma Platform

European Myeloma Platform (EMP) is a European umbrella organisation of myeloma patient support groups. In accordance with the spirit of its basic motive “Patients for Patients” it is the only pan-European myeloma patient organisation that is run by patients and their relatives for other patients, and it is politically and financially independent. EMP was founded in February 2006 in Vienna. The initiative came from patients of the six countries Austria, Belgium, Denmark, France, The Netherlands, and Switzerland. In the meantime patient groups from Germany and Portugal have joined. EMP is registered as a non-profit organisation under Belgian law. An office has been set up in Brussels.

EMP is a member of the European Cancer Patient Coalition (ECPC) and of EURORDIS, the European Organization for Rare Diseases, and is in close cooperation with the International Myeloma Foundation (IMF).

EMP also has become a partner for the EMEA (European Medicines Evaluation Agency), from which it has received the official recognition as a representative organization of European myeloma patients. EMP is involved in the review of documents addressed to patients within the framework of marketing authorisation and renewal applications of drugs.

EMP is still a rather young organisation. All myeloma patient groups in Europe are encouraged to join, because strength also lies in numbers, and it is important to make the voice of myeloma patients heard in European health politics. Membership is absolutely free.